A61K9/2846 - page 3 - CPC Classification Index

#601

20150024042

2015-01-22

PHASED DOSING OF CLOPIDOGREL

#602

20150017241

2015-01-15

Oral formulations of deferasirox

#603

20150017239

2015-01-15

METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT

#604

20150010629

2015-01-08

Controlled release and taste masking oral pharmaceutical composition

#605

20150004231

2015-01-01

Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

#606

20140377352

2014-12-25

Abuse resistant forms of extended release morphine, method of use and method of making

#607

20140377348

2014-12-25

Controlled release hydrocodone formulations

#608

20140377346

2014-12-25

BOSENTAN CONTROLLED RELEASE ORAL PREPARATION

#609

20140377345

2014-12-25

Controlled release oral pharmaceutical dosage forms comprising MGBG

#610

20140370093

2014-12-18

ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS

#611

20140370092

2014-12-18

Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

#612

20140370083

2014-12-18

5-aminosalicyclic acid capsule formulation

#613

20140356425

2014-12-04

Composition and method for treating neurological disease

#614

20140350018

2014-11-27

Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects

#615

20140341994

2014-11-20

Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

#616

20140341990

2014-11-20

Controlled release formulations of nisoldipine

#617

20140341986

2014-11-20

Biguanide compositions and methods of treating metabolic disorders

#618

20140336386

2014-11-13

Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

#619

20140335182

2014-11-13

Aqueous polymer dispersion based on N,N-diethylaminoethyl methacrylate, its preparation and use

#620

20140335181

2014-11-13

Dry coated tablet

#621

20140335176

2014-11-13

DISINTEGRANT-FREE DELAYED RELEASE DOXYLAMINE AND PYRIDOXINE FORMULATION AND PROCESS OF MANUFACTURING

#622

20140335169

2014-11-13

Peptide pharmaceutical for oral delivery

#623

20140322312

2014-10-30

Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient

#624

20140302143

2014-10-09

Controlled release and taste masking oral pharmaceutical compositions

#625

20140302139

2014-10-09

Controlled release and taste masking oral pharmaceutical compositions

#626

20140302134

2014-10-09

Formulation for the controlled release of one or several substances in the digestive tract of a mammal

#627

20140275039

2014-09-18

Abuse deterrent compositions and methods of use

#628

20140271898

2014-09-18

Abuse deterrent compositions and methods of use

#629

20140271896

2014-09-18

Tamper resistant pharmaceutical formulations

#630

20140271887

2014-09-18

Antiemetic extended release solid dosage forms

#631

20140271859

2014-09-18

Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability

#632

20140271857

2014-09-18

Benzonatate modified release solid tablets and capsules

#633

20140271840

2014-09-18

Controlled release hydrocodone formulations

#634

20140248350

2014-09-04

Delayed release film coatings containing calcium silicate and substrates coated therewith

#635

20140248344

2014-09-04

Abuse resistant forms of extended release morphine, method of use and method of making

#636

20140248343

2014-09-04

Abuse resistant forms of extended release morphine, method of use and method of making

#637

20140242166

2014-08-28

SUSTAINED RELEASE MATRIX SYSTEMS FOR HIGHLY SOLUBLE DRUGS

#638

20140205659

2014-07-24

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#639

20140199392

2014-07-17

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#640

20140199390

2014-07-17

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#641

20140199388

2014-07-17

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#642

20140199387

2014-07-17

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#643

20140193498

2014-07-10

Compositions and Methods for Treating Metabolic Disorders

#644

20140193494

2014-07-10

Misuse preventative, controlled release formulation

#645

20140180224

2014-06-26

Composition, device and method for delayed and sustained release of brain energy molecules

#646

20140154309

2014-06-05

Solid ganaxolone compositions and methods for the making and use thereof

#647

20140141092

2014-05-22

Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol

#648

20140141080

2014-05-22

Pharmaceutical compositions for the coordinated delivery of NSAIDs

#649

20140128477

2014-05-08

Enhanced moisture barrier immediate release film coating systems and substrates coated therewith

#650

20140127292

2014-05-08

Pharmaceutical compositions for the oral administration of heparin or derivatives thereof

#651

20140113921

2014-04-24

Formulations of pyrimidinedione derivative compounds

#652

20140112981

2014-04-24

Controlled release hydrocodone formulations

#653

20140099364

2014-04-10

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#654

20140093576

2014-04-03

Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures

#655

20140079779

2014-03-20

Modified release tranexamic acid formulation

#656

20140073665

2014-03-13

Modified release compositions comprising tacrolimus

#657

20140066473

2014-03-06

Modified release compositions comprising tacrolimus

#658

20140065225

2014-03-06

Modified release compositions comprising tacrolimus

#659

20140057862

2014-02-27

Formulations of histone deacetylase inhibitor and uses therof

#660

20140056980

2014-02-27

Delayed release drug formulation

#661

20140030332

2014-01-30

Chemosensory receptor ligand-based therapies

#662

20140024718

2014-01-23

Controlled release formulations of levodopa and uses thereof

#663

20140018425

2014-01-16

Controlled release formulations of levodopa and uses thereof

#664

20130337055

2013-12-19

Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection

#665

20130317115

2013-11-28

Composition and method for treating neurological disease

#666

20130317063

2013-11-28

Oral controlled release pharmaceutical compositions of bepotastine

#667

20130295013

2013-11-07

Solid composition for the oral administration of dyes and diagnostic use thereof

#668

20130287851

2013-10-31

Liquid ganaxolone formulations and methods for the making and use thereof

#669

20130287821

2013-10-31

Pharmaceutical formulation for reducing frequency of urination and method of use thereof

#670

20130287690

2013-10-31

Solid composition for the oral administration of dyes and diagnostic use thereof

#671

20130259941

2013-10-03

Controlled release dosage forms

#672

20130259932

2013-10-03

Controlled release formulations of levodopa and uses thereof

#673

20130251791

2013-09-26

Composition comprising a benzimidazole and process for its manufacture

#674

20130245154

2013-09-19

CONTROLLED RELEASE DOSAGE FORMS

#675

20130245055

2013-09-19

Pharmaceutical formulation containing gelling agent

#676

20130224264

2013-08-29

High-loading, controlled-release magnesium oral dosage forms and methods for making and using same

#677

20130196956

2013-08-01

Extended-release formulation for reducing the frequency of urination and method of use thereof

#678

20130195939

2013-08-01

Methods and compositions for oral administration of exenatide

#679

20130190336

2013-07-25

Stable pharmaceutical compositions comprising a pyrimidine-sulfamide

#680

20130189314

2013-07-25

ENTERIC-COATED HT-2157 COMPOSITIONS AND METHODS OF THEIR USE

#681

20130178492

2013-07-11

Pharmaceutical compositions comprising hydromorphone and naloxone

#682

20130177645

2013-07-11

LOW DOSAGE FORMS OF RISEDRONATE OR ITS SALTS

#683

20130177604

2013-07-11

Compositions and methods of treating metabolic disorders

#684

20130158008

2013-06-20

Solid ivabradine-containing composition

#685

20130142870

2013-06-06

Neramexane multiple unit dosage form

#686

20130122102

2013-05-16

Delivery systems for improving oral bioavailability of Fenobam, its hydrates, and salts

#687

20130115292

2013-05-09

ENTERIC TABLET

#688

20130115291

2013-05-09

Enteric tablet

#689

20130108696

2013-05-02

Coated capsules and tablets of a fatty acid oil mixture

#690

20130089611

2013-04-11

RASAGILINE CITRAMIDE

#691

20130089610

2013-04-11

R(+)-N-methyl-propargyl-aminoindan

#692

20130089606

2013-04-11

Methods and compositions for oral pharmaceutical therapy

#693

20130089604

2013-04-11

Solid oral dosage form containing an enhancer

#694

20130084333

2013-04-04

Abuse resistant oral dosage forms

#695

20130064890

2013-03-14

PHARMACEUTICAL FORMULATION BASED ON IBUPROFEN AND CODEINE HAVING IMPROVED STABILITY

#696

20130064889

2013-03-14

Tablet-in-tablet Palperidone Formulations and Methods for Production and Use Thereof

#697

20130059003

2013-03-07

SUSTAINED RELEASE DONEPEZIL FORMULATIONS

#698

20130059000

2013-03-07

Oral delivery for hemoglobin based oxygen carriers

#699

20130058867

2013-03-07

Solid composition for the oral administration of dyes and diagnostic use thereof

#700

20130053360

2013-02-28

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION

#701

20130052265

2013-02-28

Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment

#702

20130035305

2013-02-07

USE OF AN ACTIVE INGREDIENT COMBINATION THAT CONTAINS HYDROXYSTILBENE FOR PREVENTING AND/OR TREATING DISEASES

#703

20130034600

2013-02-07

Peptide pharmaceutical for oral delivery

#704

20130029947

2013-01-31

Progesterone containing oral dosage forms and kits

#705

20130022679

2013-01-24

Controlled release and taste masking oral pharmaceutical composition

#706

20130022646

2013-01-24

Controlled Release Formulations of Opioids

#707

20130022645

2013-01-24

PHARMACEUTICAL FORMULATIONS OF BISPHOSPHONATE WITH ENHANCED ORAL BIOAVAILABILITY

#708

20130017245

2013-01-17

SOLID PREPARATION

#709

20130012478

2013-01-10

Dosage forms of bisphosphonates

#710

20130011449

2013-01-10

SOLID PREPARATION

#711

20130005764

2013-01-03

QUININE DOSAGE FORMS AND METHODS OF USE THEREOF

#712

20130004577

2013-01-03

Coated tablet

#713

20130004575

2013-01-03

CONTROLLED RELEASE FORMULATIONS USING INTELLIGENT POLYMERS

#714

20130004569

2013-01-03

Oral antimicrobial pharmaceutical compositions

#715

20130004545

2013-01-03

SLOW RELEASE PHARMACEUTICAL COMPOSITIONS OF ILOPERIDONE

#716

20130004526

2013-01-03

Utilization of dialkylfumarates

#717

20120321710

2012-12-20

Controlled Release and Taste Masking Oral Pharmaceutical Composition

#718

20120316229

2012-12-13

ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS

#719

20120316228

2012-12-13

Oral antimicrobial pharmaceutical compositions

#720

20120315325

2012-12-13

Peptide pharmaceutical for oral delivery

#721

20120309959

2012-12-06

Controlled release and taste making oral pharmaceutical composition

#722

20120309779

2012-12-06

Methods and compositions comprising sequential administration opioid receptor agonists

#723

20120294947

2012-11-22

Oral Preparation Having Improved Quality

#724

20120294943

2012-11-22

Extended-release formulation for reducing the frequency of urination and method of use thereof

#725

20120288559

2012-11-15

ORGANIC COMPOUNDS

#726

20120288544

2012-11-15

NOVEL RETIGABINE COMPOSITION

#727

20120282333

2012-11-08

Delayed release pharmaceutical composition of mesalamine

#728

20120277167

2012-11-01

Oral formulations of glycyl-2-methylprolyl-glutamate

#729

20120269891

2012-10-25

Delayed release oral pharmaceutical dosage forms comprising MGBG

#730

20120269869

2012-10-25

Colon vitamin

#731

20120263789

2012-10-18

DELAYED RELEASE RASAGILINE FORMULATION

#732

20120244221

2012-09-27

EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

#733

20120237599

2012-09-20

ENTERICALLY COATED CYSTEAMINE, CYSTAMINE AND DERIVATIVES THEREOF

#734

20120232156

2012-09-13

CONTROLLED RELEASE DOSAGE FORMS

#735

20120231083

2012-09-13

SUSTAINED RELEASE CANNABINOID MEDICAMENTS

#736

20120231081

2012-09-13

CONTROLLED RELEASE DOSAGE FORMS

#737

20120231080

2012-09-13

CONTROLLED RELEASE DOSAGE FORMS

#738

20120220559

2012-08-30

Controlled Release and Taste Masking Oral Pharmaceutical Composition

#739

20120219695

2012-08-30

Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms

#740

20120219694

2012-08-30

Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms

#741

20120214917

2012-08-23

Stable protective coatings for pharmaceutical dosage forms

#742

20120213850

2012-08-23

Controlled release and taste masking oral pharmaceutical composition

#743

20120208773

2012-08-16

PHARMACEUTICAL COMPOSITIONS WITH TETRABENAZINE

#744

20120207834

2012-08-16

Oral antimicrobial pharmaceutical compositions

#745

20120189697

2012-07-26

COMPOSITIONS OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)-PHENYL]PIPERAZINE

#746

20120189670

2012-07-26

PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS INCLUDING INHIBITORS OF THE PLECKSTRIN HOMOLOGY DOMAIN AND METHODS FOR USING SAME

#747

20120189666

2012-07-26

PHARMACEUTICAL FORMULATIONS CONTAINING MICROPARTICLES OR NANOPARTICLES OF A DELIVERY AGENT

#748

20120183605

2012-07-19

QUININE FORMULATIONS, METHOD OF MAKING, AND METHOD OF USE THEREOF

#749

20120177731

2012-07-12

Controlled release formulations of levodopa and uses thereof

#750

20120177730

2012-07-12

Chemosensory Receptor Ligand-Based Therapies

#751

20120171262

2012-07-05

PHARMACEUTICAL FORMULATIONS

#752

20120165404

2012-06-28

TREATMENT OF NEURODEGENERATION AND NEUROINFLAMMATION

#753

20120164209

2012-06-28

Abuse resistant oral opioid formulations

#754

20120164193

2012-06-28

Extended-release formulation for reducing the frequency of urination and method of use thereof

#755

20120156277

2012-06-21

Abuse resistant forms of immediate release oxycodone, method of use and method of making

#756

20120143039

2012-06-07

Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles

#757

20120141584

2012-06-07

Multilayer Minitablets

#758

20120135079

2012-05-31

Modified release tranexamic acid formulation

#759

20120128766

2012-05-24

Self-breaking tablets

#760

20120122985

2012-05-17

Tranexamic acid formulations

#761

20120121702

2012-05-17

Controlled Release Azithromycin Solid Dosage Forms

#762

20120114588

2012-05-10

IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS

#763

20120108622

2012-05-03

Pharmaceutical formulation containing gelling agent

#764

20120100210

2012-04-26

Composition for the administration of polymeric drugs

#765

20120100189

2012-04-26

DELAYED RELEASE RASAGILINE MALATE FORMULATION

#766

20120094960

2012-04-19

DOSAGE FORMS OF RISEDRONATE

#767

20120093926

2012-04-19

Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid

#768

20120093904

2012-04-19

COMPOSITION COMPRISING AN ANIONIC POLYMERIC MATERIAL AND THE SALT OF A SATURATED MONOCARBOXYLIC ACID HAVING 6 TO 22 CARBON ATOMS

#769

20120093903

2012-04-19

POWDERY OR GRANULATED COMPOSITION COMPRISING A COPOLYMER, A SALT OF A FATTY MONOCARBOXYLIC ACID AND A FATTY MONOCARBOXYLIC ACID AND/OR A FATTY ALCOHOL

#770

20120076865

2012-03-29

CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES

#771

20120070465

2012-03-22

PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE

#772

20120065221

2012-03-15

Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use

#773

20120064161

2012-03-15

MODIFIED RELEASE NIACIN PHARMACEUTICAL FORMULATIONS

#774

20120064156

2012-03-15

Pharmaceutical compositions for the coordinated delivery of NSAIDs

#775

20120052098

2012-03-01

Liquid ganaxolone formulations and methods for the making and use thereof

#776

20120040000

2012-02-16

Peptide pharmaceutical for oral delivery

#777

20120034303

2012-02-09

Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix

#778

20120034274

2012-02-09

PHARMACEUTICAL COMPOSITION COMPRISING ONE OR MORE FUMARIC ACID ESTERS

#779

20120029009

2012-02-02

Tacrolimus for improved treatment of transplant patients

#780

20120027849

2012-02-02

Stable pharmaceutical composition for atherosclerosis

#781

20120021053

2012-01-26

CONTROLLED RELEASE AND TASTE-MASKING ORAL PHARMACEUTICAL COMPOSITION

#782

20120021052

2012-01-26

Controlled release and taste masking oral pharmaceutical composition

#783

20120015038

2012-01-19

Enterically coated cysteamine, cystamine and derivatives thereof

#784

20120015033

2012-01-19

Antisense compositions and methods of making and using same

#785

20120003310

2012-01-05

DELAYED RELEASE RASAGILINE FORMULATION

#786

20120003309

2012-01-05

Solid Dosage Forms Of Bendamustine

#787

20120003303

2012-01-05

ORAL ENTERIC ANTIDEPRESSANT FORMULATION

#788

20110313009

2011-12-22

NSAID DOSE UNIT FORMULATIONS WITH H2-RECEPTOR ANTAGONISTS AND METHODS OF USE

#789

20110312928

2011-12-22

Progesterone Containing Oral Dosage Forms and Related Methods

#790

20110312927

2011-12-22

Progesterone Containing Oral Dosage Forms and Related Methods

#791

20110311624

2011-12-22

Formulations of histone deacetylase inhibitor and uses thereof

#792

20110293716

2011-12-01

Pharmaceutical formulation containing ibuprofen and codeine

#793

20110293713

2011-12-01

PHARMACEUTICAL FORMULATIONS COMPRISING NSAID AND PROTON PUMP INHIBITOR DRUGS

#794

20110293711

2011-12-01

Utilization of dialkylfumarates

#795

20110287100

2011-11-24

Galenic Formulations of Organic Compounds

#796

20110287091

2011-11-24

CHRONOTHERAPEUTIC PHARMACEUTICAL COMPOSITION

#797

20110280936

2011-11-17

Self Breaking Tablets

#798

20110275659

2011-11-10

Tacrolimus For Improved Treatment Of Transplant Patients

#799

20110274754

2011-11-10

Oral tablet compositions of dexlansoprazole

#800

20110274750

2011-11-10

Enteric formulation of duloxetine and its core and preparation method

#801

20110263632

2011-10-27

Solid dispersions comprising tacrolimus

#802

20110262532

2011-10-27

Controlled release hydrocodone formulations

#803

20110256230

2011-10-20

Water insoluble polymer: indigestible water-soluble polysaccharide film coatings for colon targeting

#804

20110256190

2011-10-20

Modified release compositions comprising tacrolimus

#805

20110251232

2011-10-13

Modified release compositions comprising tacrolimus

#806

20110251231

2011-10-13

Modified release compositions comprising tacrolimus

#807

20110250277

2011-10-13

Modified release compositions comprising tacrolimus

#808

20110244050

2011-10-06

PULSED-RELEASE SILDENAFIL COMPOSITION AND METHOD FOR PREPARING SAID COMPOSITION

#809

20110244049

2011-10-06

COMPOSITIONS COMPRISING 4-(2-(5-BROMO-4-(1-CYCLOPROPYLNAPHTHALEN-4-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETAMIDO)-3-CHLOROBENZOIC ACID AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND METHODS FOR PREPARING AND USING SAME

#810

20110237675

2011-09-29

PHARMACEUTICAL FORMULATIONS

#811

20110237623

2011-09-29

Sustained-release donepezil formulation

#812

20110236487

2011-09-29

Solid ganaxolone formulations and methods for the making and use thereof

#813

20110236439

2011-09-29

Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane

#814

20110236436

2011-09-29

Pharmaceutical composition for modified release

#815

20110230559

2011-09-22

Tranexamic acid formulations

#816

20110223249

2011-09-15

Extended release compositions comprising mycophenolate sodium and processes thereof

#817

20110200680

2011-08-18

WATER INSOLUBLE POLYMER: STARCH-BASED FILM COATINGS FOR COLON TARGETING

#818

20110189242

2011-08-04

ORAL GALENIC FORM, POLYMER PRODUCTION METHOD AND USE OF SAME

#819

20110184007

2011-07-28

Pharmaceutical compositions configured to deter dosage form splitting

#820

20110177137

2011-07-21

NOVEL DOSAGE FORM OF PALIPERIDONE AND PROCESS FOR PREPARING THE SAME

#821

20110171303

2011-07-14

Dosage form containing (S)-pantoprazole as active ingredient

#822

20110159095

2011-06-30

TREATMENT OF ADRENAL INSUFFICIENCY

#823

20110159090

2011-06-30

Abuse resistant drugs, method of use and method of making

#824

20110159089

2011-06-30

Abuse resistant forms of extended release morphine, method of use and method of making

#825

20110151002

2011-06-23

Sustained release pharmaceutical compositions comprising quetiapine in non-gellable polymers

#826

20110150997

2011-06-23

ELVUCITABINE PHARMACEUTICAL COMPOSITIONS

#827

20110150991

2011-06-23

Abuse resistant forms of extended release morphine with oxycodone, method of use and method of making

#828

20110150990

2011-06-23

Abuse resistant forms of extended release hydrocodone, method of use and method of making

#829

20110150971

2011-06-23

Abuse resistant forms of extended release oxymorphone, method of use and method of making

#830

20110150970

2011-06-23

Abuse resistant forms of extended release oxycodone, method of use, and method of making

#831

20110150969

2011-06-23

Abuse resistant forms of extended release hydromorphone, method of use and method of making

#832

20110142933

2011-06-16

Controlled Release Dosage Form of Tacrolimus

#833

20110142905

2011-06-16

COATED TABLETS WITH REMAINING DEGRADATION SURFACE OVER THE TIME

#834

20110135730

2011-06-09

Oral formulations of glycyl-2-methylprolyl-glutamate

#835

20110131754

2011-06-09

Process

#836

20110130434

2011-06-02

MODIFIED RELEASE RAMIPRIL COMPOSITIONS AND USES THEREOF

#837

20110117192

2011-05-19

Carbidopa/Levodopa gastroretentive drug delivery

#838

20110076325

2011-03-31

Abuse resistant drugs, method of use and method of making

#839

20110070305

2011-03-24

SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING MEBICAR

#840

20110064820

2011-03-17

Pharmaceutical compositions comprising phosphate-binding polymer

#841

20110053866

2011-03-03

PHARMACEUTICAL COMPOSITIONS

#842

20110052688

2011-03-03

SOLID DISPERSION COMPOSITION

#843

20110052687

2011-03-03

EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF PALIPERIDONE

#844

20110052648

2011-03-03

ORAL MODIFIED-RELEASE FORMULATIONS CONTAINING THIAZEPINES

#845

20110052647

2011-03-03

Antidepressant Oral Pharmaceutical Compositions

#846

20110052556

2011-03-03

PHARMACEUTICAL COMPOSITION COMPRISING RACETAM AND CARNITINE AND PROCESS FOR ITS PREPARATION

#847

20110046053

2011-02-24

METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF EXENATIDE

#848

20110045068

2011-02-24

PHARMACEUTICAL FORMULATIONS FOR THE ORAL ADMINISTRATION OF PPI

#849

20110033532

2011-02-10

Aqueous polymer dispersion based on N,N-diethylaminoethyl methacrylate, its preparation and use

#850

20110033528

2011-02-10

STABILIZED PICOPLATIN ORAL DOSAGE FORM

#851

20110027361

2011-02-03

EXTENDED RELEASE DOSAGE FORM OF PALIPERIDONE

#852

20110027342

2011-02-03

S-ADENOSYLMETHIONINE FORMULATIONS WITH ENHANCED BIOAVAILABILITY

#853

20110020446

2011-01-27

Methods and formulations for making pharmaceutical compositions containing bupropion

#854

20110020441

2011-01-27

USE OF 5-AMINOLEVULINIC ACID AND DERIVATIVES IN A SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSIS

#855

20110014243

2011-01-20

PHARMACEUTICAL COMPOSITIONS

#856

20110002993

2011-01-06

FILM COATED TABLETS CONTAINING DROSPIRENONE AS ACTIVE AGENT AND A METHOD FOR THE PREPARATION THEREOF

#857

20110002985

2011-01-06

Abuse resistant oral opioid formulations

#858

20100323016

2010-12-23

MODIFIED RELEASE FORMULATION AND METHODS OF USE

#859

20100323015

2010-12-23

MODIFIED RELEASE FORMULATION AND METHODS OF USE

#860

20100310651

2010-12-09

Solid pharmaceutical compositions and processes for their production

#861

20100310607

2010-12-09

PHARMACEUTICAL FORMULATIONS

#862

20100303907

2010-12-02

Standardized plant extract, process for obtaining the same and uses thereof

#863

20100303904

2010-12-02

Tablet with remedial composition and methods for treating medical disorders and ailments

#864

20100303901

2010-12-02

ORAL DELIVERY OF PROTEINS AND PEPTIDES

#865

20100298268

2010-11-25

Controlled release formulations of levodopa and uses thereof

#866

20100297195

2010-11-25

CONTROLLED RELEASE LAMOTRIGINE FORMULATIONS

#867

20100291208

2010-11-18

Controlled porous osmotic pump tablets of high permeable drugs and the preparation process thereof

#868

20100291183

2010-11-18

Enhanced moisture barrier immediate release film coating systems and substrates coated therewith

#869

20100286260

2010-11-11

MILNACIPRAN FORMULATIONS

#870

20100285123

2010-11-11

Controlled Release Dosage Formulation of Duloxetine

#871

20100285120

2010-11-11

Controlled release preparation

#872

20100278917

2010-11-04

Formulations and methods of treating inflammatory bowel disease

#873

20100278911

2010-11-04

Controlled release preparation

#874

20100278909

2010-11-04

PROCESS FOR FORMING SOLID ORAL DOSAGE FORMS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS

#875

20100278152

2010-11-04

Scheduling method and system for communication networks; corresponding devices, network and computer program product

#876

20100272798

2010-10-28

CONTROLLED RELEASE PREPARATION

#877

20100260839

2010-10-14

Aqueous film coating solution, film coated granule and tablet using the same

#878

20100255099

2010-10-07

CLAVULANATE FORMULATION FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS

#879

20100255094

2010-10-07

BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS

#880

20100255082

2010-10-07

Functionally Coated Breakable Tablets

#881

20100247646

2010-09-30

EXTENDED RELEASE TABLETS OF NISOLDIPINE

#882

20100247643

2010-09-30

Oral formulations

#883

20100247640

2010-09-30

Solid oral dosage form containing an enhancer

#884

20100247489

2010-09-30

USE OF A COMPOSITION MADE OF MINERAL NUTRIENTS AND OPTIONALLY ACETOGENIC AND/OR BUTYROGENIC BACTERIA IN ORDER TO AVOID OR REDUCE THE FORMATION OF GAS IN THE LARGE INTESTINE OF A MAMMAL AND THE RESULTING ABDOMINAL PROBLEMS

#885

20100239682

2010-09-23

COLONIC DELIVERY OF ANTIMICROBIAL AGENTS

#886

20100239663

2010-09-23

Composition for foodstuff for binding acetaldehyde

#887

20100234442

2010-09-16

Compositions and Methods for Treatment and Prevention of Cardiovascular Disease

#888

20100233262

2010-09-16

Coated tablet

#889

20100222435

2010-09-02

Modified-release formulations of a bupropion salt

#890

20100222375

2010-09-02

Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day Administration

#891

20100221356

2010-09-02

PHARMACEUTICAL COMPOSITION FOR ONCE A DAY ADMINISTRATION OF TROSPIUM CHLORIDE

#892

20100221355

2010-09-02

PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE

#893

20100221354

2010-09-02

PHARMACEUTICAL COMPOSITION FOR ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE

#894

20100221353

2010-09-02

Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride

#895

20100221352

2010-09-02

PHARMACEUTICAL COMPOSITION FOR THE ONCE-A-DAY ORAL ADMINISTRATION OF TROSPIUM CHLORIDE

#896

20100215770

2010-08-26

Mixed metal compounds for treatment of hyperphosphataemia

#897

20100215743

2010-08-26

Composition and drug delivery of bisphosphonates

#898

20100209501

2010-08-19

Controlled release budesonide minitablets

#899

20100209500

2010-08-19

Controlled release budesonide minitablets

#900

20100209499

2010-08-19

Solid oral dosage form containing an enhancer